Carcinoma in situ of breast, intraductal

CD2_INSITU_BREAST_INTRADUCTAL

breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D05.1& Cause of death: ICD-10 — D05.1& 2 out of 7 registries used, show all original rules.	3132
4. Check minimum number of events None	3132
5. Include endpoints None	3132
6. Filter based on genotype QC (FinnGen only)	3132

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D05
Name in latin: Carcinoma in situ intraductale mammae

NAME	CD2_INSITU_BREAST_INTRADUCTAL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D051
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D051
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Carcinoma in situ of breast, intraductal based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Carcinoma in situ of breast, intraductal

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3132	3132	-
Unadjusted period prevalence (%)	1.07	1.07	-
Median age at first event (years)	60.34	60.34	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2756: Matched controls
27560

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

775.0

323.0

1341

HAC20

NOMESCO Finland

Total mastectomy

13.7

323.0

887

921

HAB40

NOMESCO Finland

Wedge excision of mammary gland

12.4

323.0

1022

1249

HA1AA

NOMESCO Finland

X-ray mammography

10.9

323.0

1243

1928

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

8.1

323.0

844

1425

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

10.0

323.0

1044

1583

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

11.9

323.0

817

943

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

17.7

323.0

784

606

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

97.2

323.0

441

HAB99

NOMESCO Finland

Other partial excision of mammary gland

15.4

323.0

573

463

PJA12

NOMESCO Finland

Sentinel node biopsy

26.3

323.0

1802

1845

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

4503599627370496.0

323.0

2754

115

Kela drug reimbursment

Breast cancer

6.4

318.0

1001

2255

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

23.7

308.7

453

227

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

8.3

293.5

727

1146

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

23.8

285.8

418

205

TQW20

NOMESCO Finland

Tatoe

25.1

239.4

344

156

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

12.5

237.3

449

422

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.9

211.9

1172

4393

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

12.8

211.2

394

355

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

7.3

210.0

553

914

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

11.1

200.0

401

417

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

9.6

195.6

427

519

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

7.9

185.8

460

685

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

71.3

184.2

211

C50

ICD-10 Finland

Malignant neoplasm of breast

10.1

182.9

385

436

C50.99

ICD-10 Finland

Breast, unspecified

8.6

182.7

424

569

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

10.0

169.6

358

405

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

84.8

162.6

182

L02BA01

ATC

tamoxifen; oral

6.3

158.1

460

849

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

9.3

156.3

343

414

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.0

153.1

1355

6751

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

11.1

150.6

299

XX3DW

NOMESCO Finland

Time consuming IT work

4.4

149.1

617

1685

X76

ICPC

Malignant neoplasm breast female

10.0

145.7

306

340

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

10.7

138.9

280

287

L02BG04

ATC

letrozole; oral

4.4

136.9

561

1505

ZZR10

NOMESCO Finland

Flap of skin and muscle

19.7

135.5

209

114

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

6.1

134.8

398

740

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

24.0

120.4

174

N63

ICD-10 Finland

Unspecified lump in breast

4.5

120.4

482

1251

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

9.4

115.0

249

289

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

6.7

112.7

307

508

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

33.0

108.8

144

HAE99

NOMESCO Finland

Other reconstruction of breast

15.8

108.7

182

123

D05.0

ICD-10 Finland

Lobular carcinoma in situ

72.0

108.5

124

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

9.5

107.9

231

262

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

9.2

106.1

232

273

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

21.8

105.6

157

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

4.8

105.6

384

896

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

73.6

105.3

120

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

10.9

99.9

198

194

ZZF00

NOMESCO Finland

Graft of adipose tissue

16.4

99.6

164

106

H02AB02

ATC

dexamethasone; systemic

3.3

99.2

589

2107

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

39.3

97.6

124

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

4.4

97.2

389

995

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

468.0

91.8

Z31.5

ICD-10 Finland

Genetic counselling

4.8

87.4

316

726

WF003

NOMESCO Finland

Adjuvant radiotherapy

5.3

83.5

271

552

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

7.7

83.3

203

283

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

17.1

81.2

131

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

8.1

80.8

189

247

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

10.5

78.0

157

158

XX1XN

NOMESCO Finland

Other isotope examination

11.7

75.8

144

129

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.4

74.3

236

467

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

4.9

72.3

252

553

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

12.4

72.1

133

112

ZX080

NOMESCO Finland

Image guided radiotherapy

6.5

68.8

188

308

WX702

NOMESCO Finland

Supraglottic ventilation device

4.0

67.9

296

808

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

12.1

67.5

126

109

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

9.0

67.3

147

171

A04AA02

ATC

granisetron; systemic, transdermal

3.5

67.3

351

1112

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

66.3

1223

7736

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

7.5

65.6

161

226

WX402

NOMESCO Finland

General anaesthesia

2.5

64.8

621

2904

ZXA05

NOMESCO Finland

Left side

2.1

63.4

907

5129

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

6.2

60.9

172

294

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

4.0

60.6

260

697

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

5.1

60.6

202

421

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

60.4

844

4707

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

4.8

59.1

209

464

R4110

NOMESCO Finland

Physiotherapy

2.1

58.4

904

5245

ZX090

NOMESCO Finland

Other technic of radiotherapy

5.2

58.2

189

382

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

10.3

57.5

116

117

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

6.8

56.5

148

228

HA1SA

NOMESCO Finland

Expansion mammography

16.5

55.9

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

17.2

54.5

L03AA13

ATC

pegfilgrastim; parenteral

3.6

53.5

256

752

ZXA00

NOMESCO Finland

Right side

2.0

53.2

929

5609

WZC30

NOMESCO Finland

Teaching

2.4

52.6

495

2263

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

33.2

51.9

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

6.0

51.4

148

259

N64.9

ICD-10 Finland

Disorder of breast, unspecified

8.3

51.2

117

147

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

50.6

864

5150

TQB05

NOMESCO Finland

Puncture of skin of trunk

9.5

50.6

106

115

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

5.3

50.4

161

319

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

80.2

49.1

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

5.1

48.7

160

327

ZSZ00

NOMESCO Finland

Primary repair operation

78.8

48.1

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.8

47.9

213

587

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.3

47.6

257

828

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

34.6

47.1

HAD99

NOMESCO Finland

Other plastic operation on breast

11.5

46.9

N64.5

ICD-10 Finland

Other signs and symptoms in breast

5.0

46.2

156

329

HAD40

NOMESCO Finland

Mastopexy

12.7

46.0

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

16.4

42.6

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

6.3

41.6

114

187

X21

ICPC

Breast sympt/compl female other

4.8

41.6

144

312

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

10.0

41.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

40.0

1233

8795

A04AA55

ATC

palonosetron, combinations; systemic

3.5

39.9

198

597

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

6.1

39.7

112

191

NK6AN

NOMESCO Finland

Total body bone isotope imaging

4.7

39.4

139

307

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

12.3

38.9

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.5

38.5

118

223

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

9.4

38.2

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

18.5

37.5

Z3231

NOMESCO Finland

Registered nurse

1.8

36.1

795

5062

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

13.8

35.3

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

96.3

34.8

D24

ICD-10 Finland

Benign neoplasm of breast

4.2

34.5

138

345

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

33.7

311

1387

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

9.4

33.1

N60.8

ICD-10 Finland

Other benign mammary dysplasias

11.5

33.0

A04AD12

ATC

aprepitant; systemic

4.0

32.9

137

356

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

32.7

1161

8454

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

10.1

32.3

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

3.9

31.9

135

356

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

11.8

31.9

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

6.9

31.7

118

N02BE01

ATC

paracetamol; systemic, rectal

2.0

31.5

2469

22319

8500/2-C50.5

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast

161.8

30.7

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

17.4

30.6

L02BG06

ATC

exemestane; oral

4.3

28.9

111

268

D05

ICD-10 Finland

Carcinoma in situ of breast

55.6

28.2

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

8.6

28.0

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

5.5

26.7

148

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

5.7

26.1

136

8500/2-C50.2

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast

263.0

25.7

Z3226

NOMESCO Finland

Physiotherapist

1.8

25.5

552

3438

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

7.8

25.0

HA1HA

NOMESCO Finland

Tomosynthesis mammography

7.8

24.7

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.4

24.5

228

1014

HAA10

NOMESCO Finland

Biopsy of mammary gland

6.1

24.2

113

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.7

23.8

172

666

B01AB05

ATC

enoxaparin; parenteral

1.6

23.7

895

6470

X26

ICPC

Fear of breast cancer female

6.5

23.2

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

6.0

23.1

108

QBJ00

NOMESCO Finland

Liposuction in trunk

7.4

23.0

ZXE00

NOMESCO Finland

One hour or less

1.5

22.7

1078

8195

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

3.7

22.1

100

281

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

22.1

381

2191

HAD20

NOMESCO Finland

Liposuction of breast

14.6

21.6

8500/2-C50.3

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast

221.7

21.6

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

8.5

21.6

HAD00

NOMESCO Finland

Augmentation mammoplasty

31.4

21.5

Z51.0

ICD-10 Finland

Radiotherapy session

5.4

21.5

123

1CD02

NOMESCO Finland

5.0

21.4

140

8543/3-C50.9

ICD-O-3

Paget disease and intraductal carcinoma of breast of breast, NOS

211.5

20.6

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

9.9

20.6

N62

ICD-10 Finland

Hypertrophy of breast

2.4

20.5

180

777

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

5.3

20.0

117

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

19.8

310

1721

L02BG03

ATC

anastrozole; oral

3.1

19.3

111

374

TQW99

NOMESCO Finland

Other minor procedure on skin

2.4

19.2

167

721

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

6.4

19.1

FM1FN

NOMESCO Finland

Heart function isotope examination

6.3

19.0

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

70.4

18.7

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

4.5

18.7

153

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

17.2

18.7

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

6.7

18.1

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

15.4

17.9

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

5.9

17.7

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

4.2

17.7

162

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

17.4

1096

8692

X19

ICPC

Breast lump/mass female

3.6

17.3

225

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

11.6

17.0

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

4.9

16.9

114

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

3.1

16.9

321

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

5.1

16.8

106

ZX120

NOMESCO Finland

Intravenous

1.9

16.8

264

1463

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

7.1

16.6

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

8.0

16.5

8500/2-C50.1

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast

171.0

16.5

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

5.9

16.3

L03AA14

ATC

lipegfilgrastim; parenteral

3.1

16.0

303

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

6.9

15.9

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

5.9

15.9

N06AX16

ATC

venlafaxine; oral

1.6

15.8

408

2637

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

5.6

15.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

15.2

196

1008

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.6

15.0

188

ZX112

NOMESCO Finland

Subcutaneous

3.2

15.0

253

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.4

14.9

216

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

7.6

14.9

ZZS55

NOMESCO Finland

Distension of tissue expander

25.2

14.7

N64.8

ICD-10 Finland

Other specified disorders of breast

5.8

14.6

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

5.2

14.5

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

14.5

2435

22789

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

7.2

14.3

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

3.7

14.3

171

S18

ICPC

Laceration/cut

1.4

14.1

1086

8826

HA5CB

NOMESCO Finland

Galactography

12.0

14.1

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

7.8

13.8

JN4BD

NOMESCO Finland

Extensive body CT

1.7

13.8

288

1751

PJW99

NOMESCO Finland

Other operation on lymphatic system

5.3

13.6

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

14.8

13.6

9703

FHL

Breast resection

3.7

13.0

149

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

5.3

12.8

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

4.2

12.6

114

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

12.6

172

906

1XC03

NOMESCO Finland

6.7

12.5

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

6.7

12.5

8504/2-C50.9

ICD-O-3

Encapsulated papillary carcinoma of breast, NOS

130.6

12.4

HAC25

NOMESCO Finland

Radical mastectomy

5.0

12.1

J01DB01

ATC

cefalexin; oral

1.4

11.9

2147

19749

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

11.8

166

884

HA1AE

SPAT

3.0

11.7

228

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

5.0

11.5

XX1AD

NOMESCO Finland

Other CT-examination

5.5

11.5

8500/2-C50.8

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast

+∞

11.5

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

5.1

11.4

WX400

NOMESCO Finland

Inhalation anesthesy

2.2

11.3

119

562

ZXA10

NOMESCO Finland

Bilateral

1.5

11.3

496

3609

L02AE03

ATC

goserelin; implant

4.1

11.3

107

XX2ET

NOMESCO Finland

20.1

11.1

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

13.9

11.0

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

4.7

10.9

WX110

NOMESCO Finland

Local anesthesy

1.3

10.9

1757

15740

8523/3-C50.9

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of breast, NOS

28.1

10.7

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

5.8

10.7

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

21.5

10.7

HA1BA

NOMESCO Finland

Extensive X-ray mammography

3.9

10.7

108

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

4.3

10.5

8543/3-C50.1

ICD-O-3

Paget disease and intraductal carcinoma of breast of central portion of breast

+∞

10.4

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

3.0

10.4

196

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

10.2

341

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

5.0

10.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

10.0

199

1193

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.6

10.0

261

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.1

9.9

164

HAB20

NOMESCO Finland

Excision of lactiferous duct

6.3

9.8

ZXC90

NOMESCO Finland

Use of absorbable mesh in surgery

100.4

9.4

X79

ICPC

Benign neoplasm breast female

30.1

9.4

HA1WT

NOMESCO Finland

+∞

9.4

8501/2-C50.9

ICD-O-3

Comedocarcinoma, noninfiltrating of breast, NOS

+∞

9.4

Z2221

NOMESCO Finland

Medical doctor

1.3

9.1

684

5446

WX704

NOMESCO Finland

Intubation

1.7

9.0

179

1073

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

7.0

9.0

XX2VW

NOMESCO Finland

Radiologic consultation

5.0

8.9

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

8.7

361

4819

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

3.7

8.5

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

8.5

141

802

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

6.0

8.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

3.6

8.4

101

HA1S1

NOMESCO Finland

Photography of breasts

12.8

8.4

A04AA01

ATC

ondansetron; systemic, rectal

1.7

8.3

186

1154

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

8.3

158

2442

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.1

8.2

465

M05BX04

ATC

denosumab; parenteral

1.7

8.0

156

934

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

4.1

8.0

A79

ICPC

Malignancy NOS

3.0

7.9

140

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

2.3

7.9

290

HA1DA

NOMESCO Finland

Restricted mammography

9.4

7.8

SPAT1269

SPAT

Other puncture and/or drainage

4.0

7.7

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.5

7.7

SPAT1153

SPAT

Removal of sutures

1.3

7.6

800

6655

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

6.2

7.5

D50.1

ICD-10 Finland

Sideropenic dysphagia

13.4

7.4

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

8.4

7.3

ZSZ10

NOMESCO Finland

Secondary repair operation

9.4

7.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

7.2

593

4763

QBA00

NOMESCO Finland

Puncture of skin of trunk

4.6

7.2

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

2.8

7.2

149

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

3.6

7.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

7.1

209

1389

SPAT1152

SPAT

Removal of foreign body from under the skin

2.1

7.1

361

ZXD20

NOMESCO Finland

Day surgery

1.4

7.1

335

2465

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.0

QBJ99

NOMESCO Finland

Other aesthetic correction of skin of trunk

13.8

6.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.7

6.8

155

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

3.1

6.8

115

ZZR30

NOMESCO Finland

Flap of muscle

5.7

6.7

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

12.3

6.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

6.6

204

2868

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

3.7

6.6

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

6.5

214

1462

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

6.5

147

920

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.9

6.4

120

PD2BD

NOMESCO Finland

Extensive CT angiography of pelvic organs

70.0

6.4

ZZS50

NOMESCO Finland

Insertion of tissue expander

26.7

6.2

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

6.2

178

1181

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

6.2

344

WF002

NOMESCO Finland

Radical radiotherapy

2.0

6.1

337

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768793) Breast Pathology biopsy report

794

1037

9.92

307.65

1.4

1.3

—

(4035726)

1014

2750

4.97

307.65

1.5

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

292

367

8.67

219.61

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

434

837

5.86

218.59

3.3

3.6

u/ml

33.0

30.6

0.09

417

816

(3002256) Pathology report gross observation

865

3741

2.81

132.34

1.4

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1938

12886

2.32

109.69

3.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2105

14813

2.28

99.36

7.4

6.1

umol/l

9.4

10.2

3.38

2029

13993

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2760

21999

3.14

99.03

9.3

7.6

u/l

77.4

78.6

0.97

2668

20606

(3044640) Blood type and Crossmatch panel - Blood

1417

8710

2.14

91.76

2.3

2.2

—

(40768804) Tissue Pathology biopsy report

1835

12457

2.14

91.41

2.6

2.1

—

(40768795) Lymph node Pathology biopsy report

171

338

5.29

82.24

1.1

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2156

16177

2.07

74.57

9.7

9.4

e9/l

3.6

3.9

14.47

1931

14135

(3015377) Calcium [Moles/volume] in Serum or Plasma

1536

10377

1.94

70.38

4.5

3.4

mmol/l

2.4

5.81

1371

8993

(40758558) Short blood count panel - Blood

1169

7281

1.97

67.36

6.6

6.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

118

243

5.01

54.04

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1014

6601

1.79

46.97

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

577

3248

1.95

41.68

3.5

3.8

ug/l

20.0

23.6

0.13

446

2574

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

195

871

2.32

25.35

1.2

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

438

2632

1.77

24.70

1.9

2.1

g/l

0.2

8.97

420

2480

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1616

13235

1.46

23.01

5.0

5.4

mmol/l

1.2

2.24

1461

11920

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1736

14571

1.43

20.67

6.0

6.1

mmol/l

1.2

1.07

1463

12217

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2824

26321

1.74

18.77

14.2

12.8

ml/min/173m2

80.8

78.7

8.41

2491

21642

(40758358) Immune stain study

10.06

17.59

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3040

29184

2.42

16.30

18.1

16.1

umol/l

68.1

69.7

4.46

3040

29175

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3045

29298

2.42

15.43

12.9

11.0

u/l

24.0

0.06

2956

28243

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

345

2.57

14.74

1.2

1.4

nmol/l

0.4

0.3

0.86

232

(3019550) Sodium [Moles/volume] in Serum or Plasma

2991

28639

1.99

14.42

15.6

15.4

mmol/l

139.8

0.08

2938

27952

(40761511) CBC panel - Blood by Automated count

2972

28399

1.91

14.39

14.4

13.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

231

2.90

14.22

1.1

1.2

—

(3042936) Bacteria identified in Isolate by Culture

514

3646

1.49

14.15

1.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2991

28710

1.93

13.22

15.8

15.5

mmol/l

3.9

2.44

2933

27970

(3007461) Platelets [#/volume] in Blood

3093

30128

3.14

12.58

23.1

20.7

e9/l

259.6

263.3

2.58

3051

29372

(3024731) MCV [Entitic volume]

3093

30138

3.11

12.37

23.1

20.7

91.3

91.2

0.54

3070

29718

(3035941) MCH [Entitic mass]

3093

30140

3.10

12.33

23.0

20.6

30.2

0.03

3070

29719

(3026361) Erythrocytes [#/volume] in Blood

3093

30142

3.10

12.29

23.1

20.7

e12/l

4.4

2.77

3039

29288

(3024561) Albumin [Mass/volume] in Serum or Plasma

1433

12252

1.31

12.27

4.1

4.4

g/l

36.3

35.7

5.17

1302

11323

(3010813) Leukocytes [#/volume] in Blood

3093

30144

3.09

12.25

23.2

20.8

e9/l

6.2

6.5

9.92

3043

29284

(3000963) Hemoglobin [Mass/volume] in Blood

3093

30147

3.09

12.19

23.2

20.8

g/l

131.1

132.1

4.88

3071

29731

(3018418) pH of Serum or Plasma

1075

8891

1.32

11.48

3.9

7.4

0.62

191

1690

(3003694) ABO and Rh group [Type] in Blood

845

6780

1.34

11.07

1.3

—

(3044889) 12 lead EKG panel

2177

19936

1.30

10.09

3.6

3.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2864

27403

1.53

9.87

14.4

13.7

mg/l

21.8

21.0

0.65

2250

21534

(3023368) Bacteria identified in Blood by Culture

790

6532

1.28

7.86

3.9

4.1

—

(3033658) Prothrombin time (PT) actual/Normal

834

6971

1.27

7.54

3.5

3.6

97.0

95.4

1.05

807

6771

(3007853) Bacteria identified in Skin by Aerobe culture

392

2987

1.36

6.97

1.5

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1731

15837

1.21

6.24

3.9

4.1

mmol/l

6.5

6.6

1.94

1640

14815

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1466

13206

1.21

6.22

2.3

nmol/l

81.2

80.5

0.43

1297

11881

(3019225) pH of Specimen

391

3038

1.33

6.09

4.1

4.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1033

9042

1.21

5.81

3.6

3.2

u/l

28.7

31.9

2.11

987

8560

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

576

1.67

5.26

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

662

5590

1.23

5.23

2.9

mmol/l

2.5

0.04

576

4908

(3009542) Hematocrit [Volume Fraction] of Blood

2544

24350

1.24

5.10

17.1

15.1

38.5

38.9

1.00

1810

16979

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

320

2487

1.32

4.98

2.7

3.9

u/ml

137.1

60.1

0.38

307

2393

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

356

2814

1.30

4.90

2.9

3.2

—

(3002385) Erythrocyte distribution width [Ratio]

2373

22590

1.21

4.82

19.3

17.0

13.6

13.7

2.78

2347

22094

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

763

6613

1.20

4.58

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

108

723

1.51

4.02

1.5

1.6

—

(40768443) Skin Pathology biopsy report

183

1356

1.37

3.95

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

173

1274

1.38

3.89

1.3

iu/l

41.7

39.3

0.41

152

1111

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

382

1.69

3.85

1.2

u/l

62.7

58.5

0.22

263

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

441

3721

1.22

3.45

4.6

33.9

33.5

0.38

272

2436

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1854

17513

1.14

3.35

3.1

u/l

48.4

44.4

0.94

1696

16139

(3032080) INR in Blood by Coagulation assay

1151

10538

1.15

3.30

6.1

7.8

inr

1.1

1.2

2.15

305

3057

(3013512) EKG study

931

8410

1.15

3.22

3.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

759

8458

0.86

3.04

3.5

3.8

mg/mmol

3.1

7.5

7.10

394

4765

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

223

0.36

2.91

1.1

—

(42870588) Differential panel, method unspecified - Blood

1027

9428

1.13

2.71

5.5

5.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1068

0.69

2.67

1.6

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.90

2.58

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

164

2079

0.78

2.56

2.0

2.2

ug/l

4.9

5.8

0.31

133

1780

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

142

1.91

2.55

1.2

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

411

1.52

2.54

1.3

1.4

u/l

36.3

40.9

0.45

333

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

2.42

0.0

1.3

—

17.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

145

1.87

2.41

1.9

1.8

ug/l

19.8

6.0

0.34

(3052851) Hemolysis interference index of Serum or Plasma

113

846

1.35

2.41

3.0

3.2

—

(3012516) Albumin [Mass/volume] in Urine

731

8051

0.88

2.39

2.9

3.1

mg/l

672.9

539.9

0.20

373

4501

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

6.26

2.37

1.0

1.8

—

(3009508) Creatinine [Moles/volume] in Urine

761

8346

0.88

2.32

2.8

3.0

mmol/l

6.4

0.07

626

6938

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

207

1.70

2.30

1.3

1.2

u/l

10.7

19.7

1.60

180

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

234

1.63

2.17

2.2

3.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

130

1.85

2.12

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

130

1.85

2.12

1.5

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.91

2.07

1.9

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.33

2.04

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

553

6139

0.88

2.03

1.6

1.7

pmol/l

82589759.2

32565525.0

0.62

448

5033

(3018010) Neutrophils/100 leukocytes in Blood

1381

13058

1.10

2.00

5.5

5.9

57.0

56.6

0.56

1275

12125

(3002173) Hemoglobin [Mass/volume] in Arterial blood

269

2288

1.19

2.00

6.2

7.1

g/l

117.9

118.8

0.34

257

2205

(3024980) IgG subclass 4 [Mass/volume] in Serum

439

0.59

1.98

1.2

1.5

g/l

0.7

0.01

324

(3021589) Normoblasts [#/volume] in Blood

1300

12263

1.10

1.97

9.4

e9/l

0.0

0.76

1052

9988

(3002030) Lymphocytes/100 leukocytes in Blood

1398

13238

1.10

1.95

5.6

6.2

27.7

28.8

2.90

1287

12241

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

354

1.48

1.95

2.0

2.1

mg/l

16.7

25.0

1.11

(3017569) Oxygen content in Arterial blood

1.94

1.95

2.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

473

0.61

1.94

2.0

1.8

nmol/l

1.1

0.8

1.00

392

(3019069) Monocytes/100 leukocytes in Blood

1367

12938

1.10

1.92

5.9

6.4

8.5

8.4

0.57

1270

12048

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1262

0.76

1.92

1.4

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.19

1.88

2.3

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

284

1.52

1.87

3.1

3.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

724

1.32

1.86

4.9

2.3

198.7

194.4

0.15

695

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.65

1.86

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

229

1.58

1.84

1.6

1.5

u/l

2.6

5.0

1.12

109

(3036489) Thrombin time

122

964

1.28

1.84

2.5

1.8

21.1

21.3

0.11

105

828

(3000093) Morphology [Interpretation] in Blood Narrative

198

1.62

1.83

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

175

1.66

1.82

1.4

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

183

0.44

1.80

2.1

2.0

ug/l

1.4

3.9

—

165

(3006504) Eosinophils/100 leukocytes in Blood

1357

12868

1.10

1.80

5.6

6.0

2.7

2.8

0.76

1250

11918

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

174

1438

1.22

1.78

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

532

0.65

1.74

2.7

2.4

ug/min

126.5

73.0

0.20

309

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

262

2256

1.18

1.72

2.7

2.5

ml/min/173m2

66.5

65.2

0.23

923

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.92

1.72

2.3

1.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.85

1.71

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

177

0.45

1.69

2.4

2.1

ug/l

1.4

3.0

—

150

(3009214) Lutropin [Units/volume] in Serum or Plasma

316

1.46

1.68

1.1

1.2

u/l

21.4

21.8

0.05

253

(44816559) Phosphatidylethanol [Mass/volume] in Blood

368

0.59

1.66

1.5

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

178

1487

1.21

1.65

6.4

7.4

0.8

0.7

4.03

178

1478

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

428

0.63

1.64

1.0

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

181

1.61

1.63

1.4

1.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

179

1500

1.21

1.61

6.4

7.3

1.3

0.22

179

1491

(3029937) Albumin [Presence] in Urine by Test strip

672

7280

0.90

1.60

3.8

4.6

estimate

0.0

1.08

217

2466

(3003396) Base excess in Arterial blood by calculation

318

2798

1.15

1.60

5.6

6.4

mmol/l

1.1

1.3

0.42

259

2210

(3014007) Fractional oxyhemoglobin in Arterial blood

180

1511

1.20

1.60

6.3

7.3

95.0

94.0

2.02

180

1506

(3016502) Oxygen saturation in Arterial blood

279

2433

1.16

1.58

6.0

6.8

96.5

95.9

1.45

269

2342

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

605

6574

0.90

1.53

1.3

u/ml

2.0

1.7

0.10

139

1726

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

696

1.29

1.50

3.2

2.4

g/l

3.5

0.12

665

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.86

1.50

1.0

1.1

—

17.0

—

(3022096) Basophils/100 leukocytes in Blood

1312

12497

1.09

1.50

5.6

6.1

0.7

0.08

1211

11574

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

268

1.46

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

980

10382

0.92

1.44

3.8

4.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

328

0.61

1.43

1.3

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

444

4023

1.12

1.43

2.6

2.7

e6/l

4.5

4.4

0.05

224

2040

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

127

1043

1.23

1.43

2.9

3.2

u/ml

322.6

816.4

0.76

105

886

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

233

2023

1.16

1.42

1.8

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

290

0.58

1.42

1.2

1.4

g/l

7.0

6.9

—

202

(3028192) IgG subclass 2 [Mass/volume] in Serum

289

0.59

1.41

1.2

1.4

g/l

3.0

2.7

—

201

(3024139) IgG subclass 3 [Mass/volume] in Serum

289

0.59

1.41

1.2

1.4

g/l

0.6

0.4

—

203

(40761535) Cells panel - Urine sediment

197

2287

0.85

1.40

3.0

3.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

337

0.62

1.38

1.4

1.2

mmol/l

6.8

7.7

0.73

247

(3020876) Protein [Mass/time] in 24 hour Urine

211

0.52

1.38

2.0

1.7

—

0.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

121

0.41

1.37

2.6

4.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

408

0.66

1.36

1.1

u/ml

0.5

1.2

0.99

146

(1616796) Gas panel - Central venous blood

514

0.70

1.36

4.5

3.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

315

2805

1.14

1.36

5.5

6.3

kpa

13.9

12.7

2.50

300

2669

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

315

2808

1.14

1.34

5.5

6.3

kpa

5.2

5.1

0.88

301

2677

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

224

1.48

1.33

2.1

2.3

u/field

1.1

2.3

1.17

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

807

8595

0.92

1.33

1.9

2.1

u/l

134.8

152.1

0.67

743

8015

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

177

1518

1.18

1.28

1.8

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

915

0.78

1.28

1.2

1.7

g/l

1.1

1.2

1.76

865

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

146

1.58

1.25

2.0

u/field

0.6

2.2

2.92

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

607

0.74

1.24

1.4

e6/l

872.1

1486.9

0.36

485

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

606

0.74

1.22

1.4

1.3

e6/l

49.4

23.1

0.31

454

(3017732) Neutrophils [#/volume] in Blood

229

2013

1.15

1.22

2.9

e9/l

3.8

4.0

0.61

174

1551

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.80

1.21

1.3

1.1

78.3

95.0

—

(4062490)

288

0.62

1.20

1.2

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

392

1.33

1.19

1.6

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

784

1.23

1.18

2.6

2.0

94.9

94.2

0.12

718

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.11

1.18

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.11

1.18

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.11

1.18

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

393

1.33

1.18

1.6

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

348

3151

1.12

1.17

2.6

2.5

umol/l

9.4

6.7

1.01

297

2702

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

1.16

0.0

1.2

—

1.6

—

(3022475) Manganese [Moles/volume] in Blood

2.50

1.15

1.4

1.3

—

(21494434) Karyotype in Bone marrow

207

1.45

1.15

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

395

1.32

1.14

1.6

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1032

0.81

1.14

3.1

3.5

44.3

48.0

0.71

1018

(3008898) HLA-B27 [Presence]

932

0.80

1.13

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

396

1.32

1.13

1.6

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

103

1.65

1.12

2.3

2.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

243

1.40

1.09

1.4

5.2

mmol/l

7.3

7.1

0.10

205

(4027681)

138

0.51

1.09

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1908

18573

1.07

1.09

4.7

4.8

e6/l

1647.8

2233.8

0.26

232

(3037756) Immunofixation for Serum or Plasma

549

1.26

1.09

2.0

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.19

1.08

2.9

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

848

0.80

1.07

1.4

1.6

iu/ml

0.2

0.3

0.01

174

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

252

2812

0.89

1.06

1.3

1.5

—

(3019977) pH of Arterial blood

121

1.57

1.05

4.8

3.9

7.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.27

1.03

2.2

1.9

umol/l

67.4

42.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

887

0.81

1.03

1.2

1.7

g/l

0.2

0.23

838

(3024354) Oxygen [Partial pressure] in Venous blood

151

1739

0.86

1.02

2.4

2.9

kpa

4.4

4.6

0.34

142

1682

(3008401) Mugwort IgE Ab [Units/volume] in Serum

335

0.68

1.02

1.0

1.1

u/ml

1.8

1.2

—

129

(3051651) Icteric interference index of Serum or Plasma

171

1.47

1.02

3.6

3.5

—

(3052592) Norovirus Ag [Presence] in Stool

1.92

1.02

2.0

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

263

0.64

1.01

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

345

0.69

1.00

1.0

1.1

u/ml

11.8

2.1

0.75

149

(3023410) Appearance of Cerebral spinal fluid

274

0.65

1.00

1.6

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

189

2136

0.88

0.99

2.9

3.4

kpa

5.8

0.17

181

2080

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

274

2476

1.12

0.98

2.9

3.2

ng/l

77.4

80.0

0.26

230

2084

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

508

5445

0.92

0.98

1.3

u/ml

10.6

14.1

0.60

188

2090

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.97

0.0

2.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

149

1295

1.16

0.97

7.5

8.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

310

1.33

0.96

1.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

724

0.80

0.95

1.6

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

282

0.67

0.95

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

399

1.28

0.95

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

408

1.28

0.94

1.7

1.4

—

(4034850)

909

0.82

0.93

8.4

9.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

197

0.61

0.93

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

197

0.61

0.93

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

276

2504

1.11

0.93

3.3

3.7

mmol/l

1.2

0.96

250

2174

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.73

0.92

1.1

1.4

3.5

5.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

475

4426

1.09

0.92

3.0

3.1

mmol/l

0.8

1.48

436

4086

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

721

0.80

0.92

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

196

0.61

0.92

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

196

0.61

0.92

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

160

1816

0.87

0.91

1.3

u/ml

168.5

167.3

0.01

145

1670

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

305

1.32

0.90

4.7

6.8

mg/l

12.3

12.1

0.07

282

(4015189)

1.75

0.90

1.5

2.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

519

5536

0.93

0.89

1.4

g/l

2.2

2.3

0.77

255

3182

(3036481) Cortisol [Moles/volume] in Serum or Plasma

240

2651

0.90

0.88

2.4

2.2

nmol/l

384.1

374.3

0.32

214

2434

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

119

1.52

0.88

1.6

2.3

37.5

44.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.65

0.88

1.1

74.4

88.0

—

(3006653) Thiamine [Moles/volume] in Blood

130

0.54

0.87

1.0

1.3

nmol/l

130.0

129.6

—

130

(3019150) Specific gravity of Urine by Refractometry

560

5949

0.93

0.87

4.0

4.6

kg/l

1.0

0.19

924

(21494755) Public health laboratory ask at order entry panel

169

1904

0.88

0.87

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1955

19118

1.06

0.87

4.5

4.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.00

0.87

1.5

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

192

0.62

0.85

1.5

2.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

216

0.65

0.85

1.1

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

239

0.67

0.84

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

363

3359

1.09

0.84

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

647

6828

0.93

0.84

2.4

umol/l

7521.8

4464.4

0.84

541

5834

(3000850) Epithelial cells [#/volume] in Urine

521

5536

0.93

0.82

2.4

2.5

e6/l

7.6

7.5

0.02

442

4842

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

850

0.83

0.81

1.2

1.3

u/ml

2.7

8.4

—

165

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

201

0.65

0.81

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

409

1.25

0.81

1.5

1.8

u/l

2560.6

1314.0

0.32

178

(3018677) aPTT in Platelet poor plasma by Coagulation assay

409

3812

1.08

0.80

2.1

2.0

29.2

29.3

0.08

392

3700

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.70

0.80

1.0

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

248

0.68

0.80

1.0

1.1

u/ml

5.9

2.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

838

0.83

0.80

1.2

1.3

u/ml

2.0

5.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

363

0.74

0.80

1.1

iu/ml

32.8

1713.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

582

1.21

0.80

3.4

3.5

mg/l

28.1

25.1

0.30

346

(3025018) Bordetella pertussis Ab [Titer] in Serum

176

0.62

0.79

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

142

1253

1.14

0.79

6.9

7.5

mmol/l

24.4

24.5

0.08

136

1166

(3020961) Endomysium IgA Ab [Titer] in Serum

118

1351

0.87

0.79

1.1

titre

523.0

220.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.3

—

181.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

441

4128

1.08

0.78

1.9

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

300

2763

1.09

0.78

4.4

4.3

u/l

256.3

247.3

0.32

280

2609

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

628

0.81

0.77

2.2

2.4

—

(3051611) Lipemic interference index of Serum or Plasma

313

1.28

0.77

3.5

3.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

198

0.66

0.76

1.0

mg/l

324.3

295.5

—

170

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.77

0.76

1.0

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

982

10198

0.95

0.76

3.2

3.4

ng/l

46.9

85.1

0.36

649

6739

(44790048)

270

1.30

0.76

1.2

1.4

—

(44790049)

270

1.30

0.76

1.2

1.4

—

(44790047)

270

1.30

0.76

1.2

1.4

—

(44806118)

270

1.30

0.76

1.2

1.4

—

(3025941) Bacteria identified in Stool by Culture

179

1609

1.12

0.75

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.64

0.75

1.0

—

(3020491) Glucose [Moles/volume] in Blood

175

1.37

0.74

1.2

1.6

mmol/l

6.3

6.7

0.42

114

(3028717) Thiamine [Mass/volume] in Blood

2.09

0.74

1.0

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.67

0.74

1.1

1.4

18.0

20.6

—

(3014051) Protein [Presence] in Urine by Test strip

722

0.83

0.74

2.4

2.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

177

1964

0.90

0.74

6.1

6.8

mmol/l

8.7

9.1

0.31

165

1877

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

266

0.71

0.73

1.4

1.2

—

41.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

524

1.21

0.73

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

524

1.21

0.73

1.2

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

108

1.48

0.73

1.1

—

(3002032) Base excess in Venous blood by calculation

193

2129

0.90

0.72

2.9

3.5

mmol/l

2.3

2.1

0.23

162

1784

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

106

0.57

0.72

1.2

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

265

0.72

1.4

1.2

—

54.8

—

(3011412) CD3 cells [#/volume] in Blood

238

1.31

0.70

3.2

2.1

e9/l

1.3

1.1

0.37

153

(3021440) Promyelocytes/100 leukocytes in Blood

209

2291

0.91

0.70

3.5

4.0

0.2

0.09

588

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1071

0.86

0.70

1.8

2.6

0.6

0.06

1024

(3024869) Neuronal Ab [Presence] in Serum

1.71

0.70

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

145

0.62

0.69

2.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

195

1.34

0.69

1.7

2.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2176

21410

1.05

0.68

4.1

4.4

mm/h

12.8

13.0

0.36

1990

19791

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.85

0.68

1.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.85

0.68

3.6

7.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

110

1.46

0.68

2.8

2.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

876

0.85

0.68

1.4

1.7

—

336.9

—

(3004616) Nuclear Ab [Presence] in Serum

408

0.78

0.68

1.4

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

127

1.42

0.68

1.4

1.7

pmol/l

15.0

15.3

0.09

105

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

152

1689

0.89

0.67

2.4

—

(3033799) Differential panel - Peritoneal fluid

0.55

0.67

1.2

1.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

227

2083

1.10

0.66

5.2

5.8

mmol/l

1.2

0.02

219

2017

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.53

0.66

2.2

1.6

ug/l

7.9

9.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.79

0.66

1.0

1.1

—

(3025159) Blasts/100 leukocytes in Blood

198

2167

0.91

0.65

3.4

4.0

0.1

0.5

0.80

502

(4094501)

776

0.85

0.65

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

112

989

1.14

0.65

1.7

1.8

—

(3008295) Osmolality of Serum or Plasma

323

1.24

0.63

1.2

1.4

mosm/kgh2o

276.9

274.6

0.29

251

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

112

1.43

0.63

1.9

3.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

633

0.83

0.63

3.4

3.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

114

1282

0.89

0.62

1.3

u/ml

0.2

1.5

—

128

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

261

1.27

0.62

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

291

0.75

0.62

1.0

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

287

2672

1.08

0.62

2.3

2.2

u/l

34.3

38.7

0.66

235

2264

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.59

0.61

1.2

1.4

ng/l

62.1

78.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

539

5658

0.94

0.61

1.3

iu/ml

32.9

35.0

0.13

174

1856

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

222

0.72

0.61

3.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

222

0.72

0.61

3.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

222

0.72

0.61

3.7

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

235

1.28

0.61

1.2

1.4

e6/l

139675.6

75780.1

0.33

130

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

191

1.31

0.61

1.5

1.8

14.6

13.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

472

4477

1.06

0.60

2.5

e6/l

1.3

1.5

0.61

252

2480

(3014133) Dog dander IgE Ab [Units/volume] in Serum

267

0.75

0.60

1.0

u/ml

8.2

2.8

—

(3023520) Reticulocytes [#/volume] in Blood

183

2000

0.91

0.60

2.2

2.6

e9/l

69.7

71.7

0.37

128

1483

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.9

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.60

0.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.59

0.0

1.2

—

7.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.58

0.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

365

0.79

0.58

1.8

2.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

787

0.86

0.57

1.5

2.2

ug/l

407.3

727.9

0.51

728

(3041096) Erythrocytes [Presence] in Urine by Automated

689

7167

0.95

0.57

3.3

3.7

—

(3022145) Colonoscopy Study observation

361

3403

1.07

0.57

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

136

1502

0.90

0.56

1.7

1.8

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.57

0.56

1.0

1.2

pmol/l

246.4

330.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

200

2167

0.92

0.56

2.4

2.8

ng/l

132.4

161.4

0.81

175

1984

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.46

0.56

1.1

1.0

—

(3049717) Cytology report of Urine Cyto stain

700

1.15

0.55

2.1

2.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

204

2207

0.92

0.55

3.4

3.8

0.9

0.6

0.93

459

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

691

1.15

0.55

1.6

1.3

—

(3044941) Cell count panel - Synovial fluid

458

1.18

0.55

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

373

0.80

0.55

1.2

u/l

45.0

25.1

0.68

321

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

151

1376

1.10

0.54

1.4

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.50

0.54

1.3

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

303

2846

1.07

0.54

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

151

1.33

0.54

4.1

2.1

e6/l

483.9

469.3

0.05

121

(3048879) Bone marrow aspiration report

1.45

0.53

3.1

1.8

—

(3045142) Bone marrow Pathology biopsy report

304

1.22

0.53

1.2

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

196

1.28

0.52

1.3

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.62

0.52

1.5

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

0.62

0.52

1.5

1.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

948

0.88

0.51

1.5

1.9

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

259

0.77

0.51

1.1

—

85.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

214

0.75

0.51

1.0

u/ml

1.6

0.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

197

1.27

0.51

1.2

1.4

nmol/l

1.6

1.5

0.26

177

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2562

25851

0.95

0.51

5.3

5.7

mmol/mol

39.1

39.5

2.12

2307

23792

(3000285) Sodium [Moles/volume] in Blood

1.46

0.50

1.3

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.46

0.50

4.2

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

764

1.13

0.49

1.8

2.1

g/l

0.0

0.00

699

(40768806) Pleura Pathology biopsy report

225

1.25

0.49

1.1

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

234

2502

0.93

0.49

1.3

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2304

23297

0.96

0.49

4.5

4.6

pmol/l

14.9

0.18

2070

21250

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

108

0.65

0.48

8.1

11.8

nmol/l

669.6

858.3

—

103

(40760892) CBC W Ordered Manual Differential panel - Blood

577

6000

0.95

0.48

3.8

4.6

—

(3019060) Gas panel - Arterial blood

174

1608

1.09

0.48

4.2

4.9

—

(4010399)

200

2149

0.93

0.48

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

166

0.72

0.47

1.3

1.4

—

(3021788) Differential panel - Synovial fluid

522

1.15

0.47

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

103

1140

0.90

0.47

1.7

1.6

—

(3045424) Erythrocytes [Presence] in Urine

513

1.15

0.47

1.5

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

332

0.81

0.46

5.6

4.8

u/ml

426.5

61.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

302

2854

1.06

0.46

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

150

1628

0.92

0.46

1.7

1.8

g/l

1.2

1.3

0.25

132

1479

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

165

0.73

0.46

1.0

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

873

8984

0.96

0.46

2.7

2.5

u/l

60.0

57.4

0.68

794

8214

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

749

0.88

0.46

2.7

3.2

u/ml

0.4

0.06

436

(4133840)

1.43

0.46

1.0

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

394

4128

0.95

0.45

1.3

titre

495.1

570.5

0.37

950

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

219

1.23

0.45

3.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

192

2059

0.93

0.45

2.8

2.9

g/l

9.8

10.2

0.49

166

1881

(3008152) Bicarbonate [Moles/volume] in Arterial blood

166

1538

1.08

0.44

5.8

6.8

mmol/l

25.1

24.9

0.35

152

1423

(3026389) Candida sp identified in Specimen by Organism specific culture

481

0.85

0.44

1.3

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

753

1.12

0.44

1.8

2.1

g/l

0.0

0.00

696

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

500

5202

0.95

0.43

3.3

3.5

ng/l

39.5

259.4

6.39

380

3873

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

118

1078

1.10

0.43

2.1

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

129

0.70

0.43

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

207

2209

0.93

0.43

1.2

iu/ml

124.4

149.2

0.41

874

(3017181) Myelocytes/100 leukocytes in Blood

226

2404

0.94

0.43

3.4

4.0

1.4

0.9

1.16

640

(3000012) Reticulocyte production index

151

0.73

0.42

1.8

1.5

—

(3027944) Amphetamines [Presence] in Urine

378

1.17

0.42

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.63

0.42

1.3

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

173

0.75

0.42

1.1

1.6

umol/l

4.5

8.8

—

115

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

176

1.25

0.41

2.3

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.52

0.41

1.0

1.8

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3013862) HLA-DP [Type]

0.00

0.41

0.0

1.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

631

6520

0.96

0.41

2.2

2.3

mg/l

2.9

3.0

0.50

533

5566

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

0.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

795

1.11

0.41

2.0

2.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

161

0.74

0.41

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.47

0.40

1.0

1.4

—

(3011648) Oxygen content in Venous blood

194

0.77

0.40

1.8

2.1

10.2

10.9

0.35

194

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.40

0.0

1.1

—

23.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

149

0.74

0.40

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.37

0.40

1.2

g/l

43.5

39.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

289

3041

0.95

0.40

1.5

1.6

—

(3005033) Fetal Nuchal fold Thickness US

160

0.75

0.39

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

864

1.10

0.39

1.7

2.0

g/l

38.4

37.8

0.60

737

(3010726) Horse dander IgE Ab [Units/volume] in Serum

303

0.82

0.39

1.0

u/ml

2.1

1.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.43

0.39

1.0

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

260

1.19

0.39

3.1

3.0

59.1

58.2

0.07

167

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2671

26531

1.05

0.39

5.4

5.5

mu/l

1.9

2.1

1.72

2406

24356

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

178

1.24

0.38

1.9

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

258

0.81

0.38

2.0

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

789

8103

0.96

0.38

1.7

mmol/l

1.3

1.4

1.06

659

6760

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

107

982

1.09

0.37

1.5

1.7

mg/l

2.3

3.6

0.99

717

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

197

1.22

0.37

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

136

0.73

0.37

2.6

2.8

—

20.7

—

(3000492) Spirometry study

259

2458

1.06

0.37

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.32

0.37

6.7

4.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.32

0.37

6.7

4.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

113

0.71

0.37

1.0

1.1

miu/ml

1119.3

1731.4

—

113

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.31

0.37

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2625

26424

0.96

0.37

4.0

4.1

mmol/l

1.2

1.3

1.99

2334

23947

(3000991) Gas panel - Venous blood

204

1923

1.07

0.37

6.5

7.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

116

0.69

0.37

1.0

1.4

umol/l

2.5

3.5

—

104

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

116

0.69

0.37

1.7

2.5

—

(3047189) Immunofixation for 24 hour Urine

116

0.69

0.37

3.3

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

672

0.89

0.36

1.2

—

26.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

130

1400

0.93

0.36

1.7

—

(3027008) Opiates [Presence] in Urine

384

1.15

0.36

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

189

1.22

0.36

1.4

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

234

0.81

0.35

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.66

0.35

1.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

331

0.84

0.35

2.1

2.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

522

0.88

0.35

1.3

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

341

0.85

0.34

1.3

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.36

0.34

3.3

8.4

—

(3025130) Human papilloma virus identified in Specimen

471

1.13

0.34

1.8

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

386

1.14

0.34

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.34

0.34

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

663

6449

1.04

0.34

1.5

nmol/l

22.7

21.9

0.65

539

5427

(3010421) pH of Blood

657

0.90

0.33

2.8

3.5

7.4

0.01

543

(3028300) Cannabinoids [Presence] in Urine

387

1.14

0.33

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

118

1.27

0.33

6.9

9.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

312

2991

1.05

0.32

5.4

6.1

mmol/l

104.6

104.3

0.63

305

2934

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

592

0.89

0.32

2.4

3.6

56.4

57.3

0.20

592

(4024509)

341

1.15

0.32

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

263

0.84

0.32

1.2

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

187

0.80

0.32

1.3

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.33

0.32

1.5

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

154

1637

0.94

0.32

1.3

—

(40761536) Microorganisms panel - Urine sediment

221

2323

0.95

0.32

3.7

4.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

580

0.89

0.31

1.4

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

768

0.91

0.31

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

773

1.09

0.30

1.1

u/ml

4.1

8.0

0.45

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2751

27374

1.04

0.30

4.6

4.7

mmol/l

5.8

5.9

3.68

2446

24946

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

353

1.13

0.30

1.8

1.5

59.7

55.3

0.32

207

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

259

1.16

0.29

2.5

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

222

2117

1.05

0.29

2.7

3.2

pmol/l

4.3

4.4

1.34

192

1870

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.29

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

217

0.83

0.29

1.9

1.6

u/ml

19.2

21.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

377

0.87

0.29

1.5

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

234

2448

0.95

0.29

1.4

1.6

1.3

1.4

0.28

196

2139

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

205

1955

1.05

0.28

1.2

1.3

—

(3009343) pH of Capillary blood

134

1422

0.94

0.28

3.5

7.4

1.09

197

(3006462) Nitrate [Presence] in Urine

149

1.21

0.27

3.0

3.9

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

346

1.13

0.27

3.5

3.2

nmol/l

4.2

21.0

0.53

335

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

813

0.92

0.27

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

210

2198

0.95

0.27

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

290

0.86

0.27

1.0

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

854

0.92

0.27

3.1

3.3

mg/l

26.2

110.9

0.70

695

(4281824)

490

0.90

0.27

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

287

2981

0.96

0.27

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

139

0.79

0.27

4.6

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

139

0.79

0.27

4.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

139

0.79

0.27

4.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

139

0.79

0.27

4.6

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

136

1440

0.94

0.26

3.5

kpa

5.2

0.26

130

1338

(3044290) Cell count panel - Cerebral spinal fluid

552

0.90

0.26

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

853

0.92

0.26

3.1

3.3

mg/l

41.6

42.8

0.02

692

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1148

11655

0.98

0.26

2.6

2.8

ug/l

103.6

106.7

0.24

1033

10724

(3020891) Body temperature

976

0.93

0.26

3.1

4.1

—

(3000330) Specific gravity of Urine by Test strip

136

1437

0.94

0.25

3.2

3.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

820

1.08

0.25

1.8

2.1

g/l

0.0

0.36

751

(3015183) Erythrocyte sedimentation rate

105

1.24

0.24

1.0

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

340

1.12

0.24

1.1

1.5

—

22.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

321

1.12

0.24

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

378

3668

1.03

0.24

2.3

2.4

g/l

2.4

0.22

334

3388

(3045788) Cell count panel - Pleural fluid

217

1.15

0.24

1.2

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

133

1.20

0.24

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

236

1.15

0.24

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

236

1.15

0.24

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

236

1.15

0.24

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

861

1.07

0.24

1.1

1.2

—

(40768797) Stomach Pathology biopsy report

424

4358

0.97

0.24

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

293

1.13

0.24

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

871

1.07

0.24

1.1

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1043

0.94

0.23

1.5

1.7

g/l

1.7

1.6

0.37

895

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

466

1.10

0.23

5.8

4.6

iu/ml

1316.3

277.4

—

(4146454)

294

1.12

0.23

2.1

2.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

125

0.80

0.23

1.2

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.24

0.23

1.3

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

217

2087

1.04

0.22

1.9

1.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

438

1.10

0.22

2.7

3.0

1.1

1.4

0.46

342

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.77

0.22

1.1

—

(3034426) Prothrombin time (PT)

0.76

0.22

1.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.25

0.22

3.6

8.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

189

0.85

0.22

1.0

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

855

0.93

0.22

1.9

1.8

iu/l

4.1

4.6

0.21

301

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

638

0.92

0.22

1.5

—

(3035880) pH of Pleural fluid

116

1.21

0.22

1.2

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

349

3391

1.03

0.22

2.4

20.8

21.8

0.72

292

2871

(42529406) Shigella sp [Presence] in Stool by Culture

875

1.06

0.21

1.1

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

234

2257

1.04

0.21

2.2

2.6

g/l

66.7

66.6

0.06

209

2037

(3048929) Epstein Barr virus Ab [Presence] in Serum

596

0.92

0.21

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

16.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

314.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

10.5

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.4

—

2.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

12.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.24

0.21

1.1

—

(40763590) HLA-DQ beta [Type]

0.00

0.20

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.20

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.20

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.20

0.0

1.0

—

(40757373) Influenza virus identified in Isolate

1.22

0.20

1.0

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

198

1908

1.04

0.20

2.0

2.3

—

(36304419) Bacteria [Presence] in Urine

724

7119

1.02

0.19

2.8

2.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

101

957

1.06

0.19

1.3

1.4

ug/g

305.8

284.6

0.52

546

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

918

1.06

0.19

3.5

3.6

mmol/l

25.2

25.1

0.15

847

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

197

0.86

0.19

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

182

1890

0.96

0.19

1.3

au/ml

64.9

44.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

279

1.11

0.19

2.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1595

16090

0.98

0.19

2.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

145

1389

1.05

0.19

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

186

0.86

0.19

1.0

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1192

11785

1.02

0.19

2.0

pmol/l

102.6

99.2

1.32

511

5463

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

207

0.87

0.19

1.0

ng/l

352.5

368.8

0.11

144

(3048689) Calprotectin [Mass/mass] in Stool

352

3610

0.97

0.19

2.0

ug/g

105.0

124.3

0.76

248

2790

(3023199) Leukocytes [#/volume] in Pleural fluid

270

1.11

0.18

1.2

1.4

e6/l

3782.8

2354.7

0.35

201

(3017704) Immunofixation for Urine

137

1.17

0.18

1.5

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

560

0.93

0.18

1.7

mu/l

363.1

333.2

0.18

495

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

156

1.15

0.18

1.5

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

109

1.19

0.18

1.6

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

357

1.09

0.18

1.3

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

638

1.07

0.18

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.15

0.17

9.0

2.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

145

1508

0.96

0.17

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

927

0.95

0.17

1.5

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

494

1.07

0.17

3.6

3.3

nmol/l

0.7

0.8

1.72

378

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

201

2076

0.97

0.17

2.4

au/ml

42.7

23.8

0.67

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.11

0.17

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

928

9396

0.98

0.17

2.8

3.0

—

(3026782) Osmolality of Urine

511

5016

1.02

0.17

2.4

2.7

mosm/kgh2o

490.4

503.2

0.72

414

4269

(3032057) Clostridioides difficile [Presence] in Stool

0.76

0.17

1.4

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.72

0.17

1.6

1.2

—

(3024263) Appearance of Synovial fluid

148

1.15

0.17

1.6

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

0.85

0.17

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.71

0.16

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.71

0.16

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1.11

0.16

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

234

1.11

0.16

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.16

1.1

—

(3028433) Virus identified in Specimen by Culture

101

1.19

0.16

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

162

0.86

0.16

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.11

0.16

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

401

0.92

0.16

1.4

1.2

u/ml

5.3

4.0

0.24

146

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

1024

1.05

0.16

1.7

2.2

g/l

10.1

10.0

0.05

851

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

116

1209

0.96

0.15

2.0

u/l

39.4

40.5

0.26

102

1075

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

235

1.11

0.15

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

216

1.11

0.15

1.3

1.5

g/l

1.0

0.19

216

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

1045

1.04

0.15

1.8

2.2

g/l

3.2

3.1

0.41

799

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

161

0.87

0.15

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

255

0.90

0.15

1.5

36.8

39.1

0.08

146

(3024928) Oxygen saturation in Venous blood

482

0.93

0.15

1.9

3.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

911

0.95

0.14

2.0

1.9

ug/l

3.2

1.8

0.58

811

(1761482) Bacteria [#/volume] in Urine by Culture

664

1.06

0.14

3.4

4.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

409

0.93

0.14

1.1

1.2

u/ml

296.1

286.6

0.07

241

(3033705) Calcium.ionized [Moles/volume] in Venous blood

285

1.09

0.14

1.8

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

139

0.86

0.14

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

587

1.06

0.14

2.1

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

212

0.90

0.14

1.0

ng/l

51.1

49.9

0.05

147

(3021901) Oxygen saturation in Capillary blood

398

0.93

0.14

3.1

2.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

243

0.90

0.13

6.9

6.2

—

(1002224) Polysomnography panel

1021

0.96

0.13

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

122

1.15

0.13

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

122

1.15

0.13

1.0

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

122

1.15

0.13

1.0

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

673

6643

1.02

0.13

3.4

4.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

931

1.04

0.13

1.9

2.2

g/l

0.5

0.6

0.11

802

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

412

1.07

0.13

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

346

0.92

0.13

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

598

1.05

0.13

1.9

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

109

0.83

0.13

5.4

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

109

0.83

0.13

5.4

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

109

0.83

0.13

5.4

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

106

1021

1.04

0.13

5.0

5.5

0.9

0.16

957

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2821

28148

1.02

0.13

5.1

5.2

mmol/l

2.9

0.21

2530

25792

(3000475) Leukocytes [#/volume] in Synovial fluid

707

1.05

0.12

1.8

1.6

e6/l

12752.9

9412.7

0.46

507

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

324

0.93

0.12

1.1

g/l

1.4

1.5

0.43

284

(3015076) Soybean IgE Ab [Units/volume] in Serum

104

1.15

0.12

1.0

—

0.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

641

0.95

0.12

1.3

1.2

—

(3012501) Base excess in Blood by calculation

549

0.95

0.12

3.0

3.6

mmol/l

2.3

2.8

0.96

395

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

137

0.88

0.12

1.4

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

137

0.88

0.12

2.1

2.8

u/ml

715.5

1420.6

0.83

137

(36660697) Celiac disease serology panel - Serum

247

2418

1.02

0.12

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

133

1371

0.97

0.12

3.4

3.5

mmol/l

1.8

2.0

0.30

111

1066

(3045414) Leukocytes [Presence] in Urine

135

1391

0.97

0.11

1.9

2.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

637

6296

1.01

0.11

1.8

1.7

mg/l

1.0

1.1

0.66

482

4836

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

209

0.91

0.11

1.0

ng/l

759.9

726.2

0.10

141

(3022948) Iron [Moles/volume] in Serum or Plasma

395

4011

0.98

0.11

2.3

2.4

umol/l

12.2

12.9

1.10

360

3707

(3018405) Lactate [Moles/volume] in Arterial blood

848

1.04

0.11

3.0

3.5

mmol/l

1.4

1.3

0.10

833

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2736

27416

0.98

0.10

4.5

4.6

mmol/l

1.6

5.49

2457

25111

(3016879) Cocaine [Presence] in Urine

349

1.06

0.10

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

197

0.91

0.10

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

135

0.89

0.09

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

412

0.95

0.09

1.3

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

371

0.94

0.09

1.3

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

207

0.92

0.09

1.4

1.2

u/ml

2.2

1.4

0.18

(3003338) MCHC [Mass/volume]

2272

22651

1.01

0.09

20.5

18.1

g/l

330.3

330.4

0.36

2261

22508

(3002523) Influenza virus A Ag [Presence] in Specimen

340

1.06

0.09

1.1

—

(3012441) Differential panel - Pleural fluid

213

1.08

0.09

1.1

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.04

0.09

1.0

1.1

—

(3022313) Gas panel - Capillary blood

106

1030

1.03

0.09

3.4

3.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.07

0.08

1.5

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.07

0.08

1.2

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

341

1.06

0.08

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

105

1022

1.03

0.08

4.7

5.3

1.6

0.07

955

(3009261) Glucose [Presence] in Urine by Test strip

1396

13892

1.01

0.08

3.6

4.1

estimate

0.0

1.08

224

2474

(3003129) Base excess in Capillary blood by calculation

0.83

0.08

3.4

1.8

mmol/l

3.7

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.79

0.08

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

146

1.10

0.08

1.1

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

724

7298

0.99

0.08

2.9

3.0

e6/l

0.5

0.4

0.14

513

5433

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.78

0.08

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

460

1.04

0.08

1.2

1.3

—

(3004451) EKG impression Narrative

127

1.10

0.08

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

127

1.10

0.08

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.03

0.07

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.03

0.07

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.03

0.07

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.03

0.07

1.1

—

(4211845)

166

1.08

0.07

3.0

3.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.86

0.07

1.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.86

0.07

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

439

0.96

0.07

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

451

1.04

0.07

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.07

0.07

4.3

1.8

ug/l

2.3

1.3

—

(3018095) Leukocytes [#/volume] in Urine

938

9437

0.99

0.07

3.5

3.6

e6/l

128.5

109.1

0.22

606

6445

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

333

1.05

0.07

1.4

1.5

—

(3047181) Lactate [Moles/volume] in Blood

807

1.03

0.07

5.9

6.6

mmol/l

1.1

1.2

1.81

714

(40765096) Chromosome analysis panel by Banding

1.03

0.07

1.0

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

1419

14133

1.01

0.07

5.4

5.9

e9/l

1.8

1.9

3.53

1218

12391

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

397

0.96

0.07

1.3

u/ml

76.5

120.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

437

0.96

0.06

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.11

0.06

2.2

2.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

0.92

0.06

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

142

0.92

0.06

1.3

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

457

0.96

0.06

1.2

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

111

0.90

0.06

1.0

1.1

—

(3039000) Anion gap in Blood

582

1.03

0.06

7.1

7.6

mmol/l

10.2

11.0

1.80

525

(3018572) Chloride [Moles/volume] in Blood

582

1.03

0.06

7.1

7.6

mmol/l

106.4

105.1

1.62

525

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2765

27615

1.01

0.06

4.5

4.6

mmol/l

5.0

4.9

1.96

2492

25443

(3016018) Differential panel - Cerebral spinal fluid

284

0.95

0.06

1.5

1.4

—

(3005570) Glucose [Moles/volume] in Urine

284

0.95

0.06

1.9

2.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

577

0.97

0.05

2.4

2.1

g/l

132.7

126.3

1.13

399

(3014271) Vancomycin [Susceptibility]

129

1.09

0.05

3.3

2.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

129

1.09

0.05

1.2

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

782

7779

1.01

0.05

2.9

3.1

e6/l

76.0

63.3

0.11

558

5854

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

425

1.04

0.05

1.1

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1381

13764

1.01

0.05

4.9

5.4

estimate

0.0

0.80

214

2446

(3045683) HLA typing for celiac disease panel - Blood or Tissue

159

1.07

0.05

1.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

108

1099

0.98

0.05

3.1

3.9

mmol/l

24.7

24.4

0.29

989

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

434

0.97

0.05

1.2

1.3

nmol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

364

3612

1.01

0.04

5.4

6.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.10

0.04

1.1

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

190

0.95

0.04

1.2

1.3

mmol/l

6.5

6.6

0.01

176

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

408

1.03

0.04

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

613

0.98

0.03

3.7

3.2

u/ml

97.7

919.2

1.17

554

(3035350) Ketones [Presence] in Urine by Test strip

1358

13612

1.00

0.03

3.5

4.0

estimate

0.0

0.50

220

2447

(3001604) Monocytes [#/volume] in Blood

1376

13791

1.00

0.03

5.4

5.8

e9/l

0.5

0.6

0.44

1158

11845

(3004716) Salmonella sp identified in Stool by Organism specific culture

141

1394

1.01

0.03

1.2

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

522

0.98

0.03

2.9

2.5

17.1

16.0

1.03

261

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

381

0.97

0.03

1.1

u/ml

5.6

3.1

0.25

156

(3003458) Phosphate [Moles/volume] in Serum or Plasma

338

3359

1.01

0.03

4.0

4.8

mmol/l

1.0

0.12

308

3077

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

658

1.02

0.03

1.3

miu/ml

281.4

230.9

0.45

313

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

519

1.02

0.03

1.2

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

211

1.04

0.03

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

249

0.96

0.02

1.4

1.9

—

(3038515) Glucose [Moles/volume] in Venous blood

500

1.02

0.02

2.3

2.8

mmol/l

7.5

0.02

488

(3028707) Methadone [Presence] in Urine by Screen method

188

0.96

0.02

1.1

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

266

2646

1.01

0.02

2.2

2.6

1.7

1.9

2.08

229

2340

(3000034) Microalbumin [Mass/volume] in Urine

262

1.03

0.02

2.5

2.7

mg/l

6.3

21.9

1.93

172

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

137

0.95

0.01

5.4

2.4

e6/l

373.9

730.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

511

5097

1.00

0.01

1.8

1.7

nmol/l

1049.2

1200.7

3.53

359

3816

(3013115) Eosinophils [#/volume] in Blood

1433

14345

1.00

0.01

5.6

6.1

e9/l

0.2

2.27

1230

12530

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

207

0.97

0.01

2.2

2.4

—

(4268621)

277

0.97

0.01

2.7

2.2

—

(3022621) pH of Urine by Test strip

191

1919

1.00

0.01

3.3

3.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

1103

1.01

0.00

1.8

2.2

g/l

3.7

0.03

778

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

1103

1.01

0.00

1.8

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

123

1223

1.01

0.00

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

144

1.04

0.00

1.3

1.4

u/l

11.3

12.3

0.28

136

(3006922) Hepatitis E virus Ab [Presence] in Serum

176

0.97

0.00

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

294

1.02

0.00

1.5

1.4

—

(4306422)

404

1.02

0.00

1.1

1.2

—

(3026008) Bacteria identified in Urine by Culture

970

9707

1.00

0.00

3.1

3.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

796

0.99

0.00

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

1104

1.01

0.00

1.8

2.2

g/l

7.5

7.6

0.06

819

(3006315) Basophils [#/volume] in Blood

1385

13856

1.00

0.00

5.5

5.9

e9/l

0.0

1.46

1157

11896

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

135

0.96

0.00

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

121

0.99

0.00

1.4

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

265

1.02

0.00

1.8

1.4

e6/l

8995.3

104793.9

1.41

174

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

275

1.02

0.00

1.4

1.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

191

0.99

0.00

2.4

2.0

31.8

40.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

221

1.00

0.00

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

405

0.99

0.00

1.4

1.2

—

(40768441) Liver Pathology biopsy report

229

1.00

0.00

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

435

1.01

0.00

1.9

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

445

0.99

0.00

2.3

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

759

1.00

0.00

1.6

1.4

—

(3037121) Protein [Mass/volume] in Urine

879

1.00

0.00

2.9

2.8

g/l

0.2

0.3

1.89

292

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.04

0.00

1.1

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

294

0.99

0.00

1.1

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

324

0.99

0.00

1.3

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

526

1.01

0.00

2.3

2.7

mmol/l

1.4

1.6

1.02

511

(3003181) Sodium [Moles/volume] in Urine

544

0.99

0.00

1.1

1.3

mmol/l

63.2

59.9

0.21

426

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

168

1.01

0.00

1.2

1.4

—

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

764

7639

1.00

0.00

2.6

2.8

ng/l

829.8

1033.9

1.36

635

6510

(44813793)

218

1.01

0.00

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

408

1.00

0.00

1.3

1.2

u/ml

3.8

3.3

0.08

117

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

450

4497

1.00

0.00

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

325

3248

1.00

0.00

20.9

21.6

inr

1.3

0.01

473

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

113

0.97

0.00

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

153

0.98

0.00

1.0

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.8

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

2.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.95

0.00

1.2

1.4

57.3

63.8

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.7

—

336.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

3.8

—

1.4

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.00

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

0.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

0.94

0.00

1.4

2.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

2.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.99

0.00

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

0.98

0.00

3.6

5.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.01

0.00

1.0

1.1

—

(3024932) HLA-DR beta [Type]

0.97

0.00

1.0

1.2

—

(3024471) HLA-A [Type]

0.91

0.00

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.90

0.00

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

410

1.00

0.00

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.98

0.00

1.2

1.7

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

140

1.00

0.00

1.2

1.5

nmol/l

1.0

1.2

—

109

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1308.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.99

0.00

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.98

0.00

1.0

1.1

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

270.3

—

(4198724)

0.88

0.00

1.0

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.00

0.00

1.4

1.7

u/l

20.7

90.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.98

0.00

1.2

1.1

iu/ml

144.0

192.5

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_BREAST_INTRADUCTAL – Carcinoma in situ of breast, intraductal

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Carcinoma in situ of breast, intraductal

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Carcinoma in situ of breast, intraductal (CD2_INSITU_BREAST_INTRADUCTAL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints